Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-03-24

FDA Approved: TELMISARTAN — Supplemental Application (Ascend Laboratories, LLC)

View source ↗

Summary

FDA approved a supplemental application for telmisartan submitted by Ascend Laboratories, LLC, authorizing the marketing of a generic telmisartan product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Telmisartan (Telmisartan)

Snippet

SUPPL AP for TELMISARTAN (TELMISARTAN)